Chiara Brignole

Istituto Giannina Gaslini — Italy

Medicine · Health Sciences

35h-index3.6kcitations99works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(72), Lung Cancer Research Studies(22), Cancer, Hypoxia, and Metabolism(17), Cell death mechanisms and regulation(14), Cancer therapeutics and mechanisms(13)

Publications99 total

Olive Leaf Extract (OLE) Anti-Tumor Activities Against Hematologic Tumors: Potential Therapeutic Implications for Pediatric Patients with B-Acute Lymphoblastic Leukemia
Nutrients·2025Open Access
Ganglioside Profiling Uncovers Distinct Patterns in High-Risk Neuroblastoma
International Journal of Molecular Sciences·2025· 2 citedOpen Access
THE GADEKILL GMP-CELL PRODUCT AS NOVEL IMMUNOTHERAPEUTIC TOOL FOR NEUROBLASTOMA PATIENTS RECEIVING A HAPLOIDENTICAL HSCT
Cytotherapy·2025
Abstract 6394: Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs
Cancer Research·2025
Abstract 4785: Preclinical characterization of the anti-tumor activity of the investigational anti-B7-H3 antibody-drug conjugate (ADC), vobramitamab duocarmazine (vobra duo), in pediatric sarcomas (pSC)
Cancer Research·2025
Extracellular vesicles in cancer´s communication: messages we can read and how to answer
Molecular Cancer·2025· 42 citedOpen Access
Fenretinide-Loaded Mesenchymal Stromal Cell-Derived Extracellular Vesicles as an Efficient Drug Carrier to Treat Human Neuroblastoma
SSRN Electronic Journal·2025Open Access
Abstract 3204: Antitumor activity of a coencapsulated liposomal formulation of ceramides and doxorubicin in neuroblastoma models
Cancer Research·2024
Supplementary Data from Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
2023Open Access
Data from The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
2023Open Access
Data from The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
2023Open Access
Data from Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
2023Open Access
Supplementary Data from The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
2023Open Access
Supplementary Data from Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
2023Open Access
Data from Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
2023Open Access
Supplementary Data from The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
2023Open Access
Supplementary Figure 1 from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
2023Open Access
Supplementary Methods and Figure Legend from Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
2023Open Access
Supplementary Figure S1 from Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
2023Open Access
Supplementary Methods from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Mirco Ponzoni(48), Fabio Pastorino(40), Daniela Di Paolo(30), Gabriella Pagnan(25), Patrizia Perri(25), Danilo Marimpietri(21), Michele Cilli(20), Monica Loi(16), Doménico Ribatti(15), Theresa M. Allen(13), Laura Emionite(11), Vito Pistoia(8), Angelo Corti(7), Federica Piccardi(7), Beatrice Nico(7), Maria Valeria Corrias(6), Claudio Gambini(5), Renato Longhi(5), Francesca Piaggio(5), Flavio Curnis(5)